A Multicenter Prospective Study on Efficacy and Safety of Imatinib Generics: A Report From Polish Adult Leukemia Group Imatinib Generics Registry

American Journal of Hematology - United States
doi 10.1002/ajh.24748
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Efficacy and Safety of Imatinib in Paediatric CML – A Single Centre Study

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2019English

Generics and Reverse Generics for Pharo

2012English

Sodium Stibogluconate Cardiotoxicity and Safety of Generics

Transactions of the Royal Society of Tropical Medicine and Hygiene
Public HealthEnvironmentalParasitologyMedicineInfectious DiseasesOccupational Health
2003English

Leslie on Generics

Philosophical Studies
Philosophy
2014English

Beyond Generics

Maandblad Voor Accountancy en Bedrijfseconomie
2002English

Multicenter Phase II Clinical Trial of Nilotinib for Patients With Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia From the East Japan CML Study Group Evaluation of Molecular Response and the Efficacy and Safety of Nilotinib

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

Generics: An Enigma?

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Higher Dose Imatinib for Children With De Novo Chronic Phase Chronic Myelogenous Leukemia: A Report From the Children's Oncology Group

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2011English

Generics Policies–a Globally-Relevant Implementation Challenge

GaBI Journal
Drug GuidesPharmacy
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy